Greening the pharmaceutical sector: rhetoric or reality?

Panel discussion with representatives from across the pharmaceutical sector

The pharmaceutical sector is under increasing pressure to decarbonise supply chains, to mitigate the impacts of medicines on the environment, and to shift the balance of benefits more equally across patients, planet and profits. The stakes are high for all involved. Progress is variable. Industry, regulators, healthcare providers, professional organisations and citizen groups all have potential roles to play. But what is the way forward? How can pharmaceutical companies work differently in the interests of planetary health? What incentives and levers are there for change, and across global supply chains? And how can we make this all happen rapidly, and at scale? In this panel, representatives from across the pharmaceutical sector will come together to debate these pressing issues, to consider the urgent steps needed to bring about change and how, with urgency, to make them a reality.

Speakers

• Moderator: Amy Booth, Sustainable Health Care Module Co-lead
• Mark Wilson, Executive Director, Health Care Without Harm Europe
• Martin Chilcott, Founder and CEO, Manufacture 2030
• Liz Breen, Professor of Health Service Operations, Faculty of Life Sciences University of Bradford
• Chris Winchester, CEO, Oxford PharmaGenesis